ReviewFrontiers in oncology2020

Concurrent Genetic Alterations and Other Biomarkers Predict Treatment Efficacy of EGFR-TKIs in EGFR-Mutant Non-Small Cell Lung Cancer: A Review.

Yijia Guo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.